Cargando…

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma

Background: Glioma is the most common primary intracranial tumor, accounting for the vast majority of intracranial malignant tumors. Aberrant expression of RNA:5-methylcytosine(m(5)C) methyltransferases have recently been the focus of research relating to the occurrence and progression of tumors. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng, Wu, Miaojing, Tu, Zewei, Tao, Chuming, Hu, Qing, Li, Kuangxun, Zhu, Xingen, Huang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466433/ https://www.ncbi.nlm.nih.gov/pubmed/32974125 http://dx.doi.org/10.3389/fonc.2020.01119

Ejemplares similares

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2021)

Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy
por: Li, Kuangxun, et al.
Publicado: (2021)

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer
por: Wang, Lei, et al.
Publicado: (2021)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

5-methylcytosine RNA methyltransferases and their potential roles in cancer
por: Li, Mingyang, et al.
Publicado: (2022)

Ferroptosis in tumor immunity and therapy
por: Gong, Chuandong, et al.
Publicado: (2022)

Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients
por: Wang, Peng, et al.
Publicado: (2021)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021)

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas
por: Hu, Qing, et al.
Publicado: (2020)

A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma
por: Luo, Haitao, et al.
Publicado: (2021)

Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma
por: Zhang, Ying, et al.
Publicado: (2020)

Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma
por: Pan, Qi, et al.
Publicado: (2022)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients
por: Liu, Feng, et al.
Publicado: (2022)

Development of a prognostic index based on immunogenomic landscape analysis in glioma
por: Luo, Haitao, et al.
Publicado: (2021)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
por: Liu, Junzhe, et al.
Publicado: (2022)

The Roles of Host 5-Methylcytosine RNA Methyltransferases during Viral Infections
por: Wnuk, Maciej, et al.
Publicado: (2020)

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
por: Jiang, Yuan, et al.
Publicado: (2022)

Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
por: Fang, Zhansheng, et al.
Publicado: (2022)

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma
por: Luo, Haitao, et al.
Publicado: (2021)

5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
por: Jhanwar, Shalu, et al.
Publicado: (2019)

5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
por: Wang, Ke, et al.
Publicado: (2021)

Identification of the Prognostic Signatures of Glioma With Different PTEN Status
por: Zhang, Pei, et al.
Publicado: (2021)

Comprehensive Analysis of 5-Methylcytosine (m(5)C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy
por: Wang, Ronglin, et al.
Publicado: (2022)

The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma
por: Luo, Haitao, et al.
Publicado: (2023)

DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma
por: Luo, Haitao, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020)

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Xu, Yang, et al.
Publicado: (2021)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022)

Eukaryotic 5-methylcytosine (m(5)C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease
por: Bohnsack, Katherine E., et al.
Publicado: (2019)

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
por: Tu, Zewei, et al.
Publicado: (2022)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1dq5n4kalfar6imjar0j950mgu